Outcome analysis of breast cancer patients who declined evidence-based treatment
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Surgery
Link
http://link.springer.com/content/pdf/10.1186/1477-7819-10-118.pdf
Reference10 articles.
1. National Cancer Institute of Canada: Canadian cancer statistics 2011, Toronto, ON, Canada 2011.
2. Fisher B, Anderson S, Bryant J: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002, 347: 1233-1241. 10.1056/NEJMoa022152.
3. Kuerer HM, Newman LA, Smith TL: Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol. 1999, 17 (2): 460-469.
4. Chang EY, Glissmeyer M, Tonnes S: Outcomes of breast cancer in patients who use alternative therapies as primary treatment. Am J Surg. 2006, 192: 471-473. 10.1016/j.amjsurg.2006.05.013.
5. Verkooijen HM, Fioretta GM, Rapiti E: Patients’ refusal of surgery strongly impairs breast cancer survival. Ann Surg. 2005, 242: 276-280. 10.1097/01.sla.0000171305.31703.84.
Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The effect of the COVID-19 health disruptions on breast cancer mortality for older women: a semi-Markov modelling approach;Scandinavian Actuarial Journal;2024-05-13
2. Declination of Treatment, Racial and Ethnic Disparity, and Overall Survival in US Patients With Breast Cancer;JAMA Network Open;2024-05-09
3. Natural history and prognostic model of untreated breast cancer: a study based on the SEER database;2024-03-19
4. Patient delay in initiating treatment after breast cancer diagnosis: A cause for concern;Journal of Health Science Research;2024-02-22
5. Refusal of treatment among HER2-positive breast cancer patients in China: a retrospective analysis;Frontiers in Public Health;2024-01-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3